Education
About Us
Working with TipRanks
Follow Us
Medacta Group SA (CH:MOVE)
:MOVE
MOVE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF103.60 - CHF141.00
Previous CloseN/A
Volume2.09K
Average Volume (3M)14.40K
Market Cap
$2.52B
Enterprise ValueCHF2.32B
Total Cash (Recent Filing)€27.24M
Total Debt (Recent Filing)€152.15M
Price to Earnings (P/E)36.1
Beta1.11
Next Earnings
Sep 08, 2025EPS EstimateN/A
Next Dividend Ex-Date
May 09, 2025Dividend Yield0.4%
Share Statistics
EPS (TTM)3.49
Shares Outstanding20,000,000
10 Day Avg. Volume13,134
30 Day Avg. Volume14,400
Financial Highlights & Ratios
PEG Ratio0.71
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$149.34Price Target Upside15.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Medacta Group SA News
PremiumCompany Announcements
Medacta Announces 2025 AGM Details and Key Proposals
PremiumCompany Announcements
Medacta Group SA Reports Strong 2024 Financial Growth
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMedacta released full fiscal year results that delivered a ~4% beat on Adjusted EBITDA, indicating strong financial performance.
Growth StrategyMedacta outlined a comprehensive growth strategy at their first CMD that hits the right notes around the current product opportunity set, execution and deliverable targets, and capital deployment.
Bears Say
Capital ExpenditureOperational free cash flow increased by 42%, indicating strong cash flow generation, even as capital expenditure rose, showing client traction in new product lines.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.12%
Mutual Funds
― Other Institutional Investors
95.05% Public Companies and
Individual Investors
MOVE FAQ
What was Medacta Group SA’s price range in the past 12 months?
Medacta Group SA lowest stock price was CHF103.60 and its highest was CHF141.00 in the past 12 months.
What is Medacta Group SA’s market cap?
Medacta Group SA’s market cap is $2.52B.
When is Medacta Group SA’s upcoming earnings report date?
Medacta Group SA’s upcoming earnings report date is Sep 08, 2025 which is in 136 days.
How were Medacta Group SA’s earnings last quarter?
Medacta Group SA released its earnings results on Mar 25, 2025. The company reported CHF1.653 earnings per share for the quarter, beating the consensus estimate of N/A by CHF1.653.
Is Medacta Group SA overvalued?
According to Wall Street analysts Medacta Group SA’s price is currently Undervalued.
Does Medacta Group SA pay dividends?
Medacta Group SA pays a Semiannually dividend of CHF0.344 which represents an annual dividend yield of 0.4%. See more information on Medacta Group SA dividends here
What is Medacta Group SA’s EPS estimate?
Medacta Group SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medacta Group SA have?
Medacta Group SA has 20,000,000 shares outstanding.
What happened to Medacta Group SA’s price movement after its last earnings report?
Medacta Group SA reported an EPS of CHF1.653 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.024%.
Which hedge fund is a major shareholder of Medacta Group SA?
Currently, no hedge funds are holding shares in CH:MOVE
---
Company Description
Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
---
MOVE Company Deck
---
MOVE Earnings Call
Q4 2025
0:00 / 0:00
---
MOVE Stock 12 Month Forecast
Average Price Target
CHF149.34
▲(15.23% Upside)
Technical Analysis
Straumann Holding AG
―
Tecan Group AG
―
Ypsomed Holding AG
―
medmix AG
―
Medartis Holding AG
―
Best Analysts Covering MOVE
1 Year
1 Year Success Rate
3/3 ratings generated profit
1 Year Average Return
+8.40%
reiterated a buy rating last month
Copying Aisyah Noor's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +8.40% per trade.
---